Morten Herholdt
Stock Analyst at HSBC
(1.07)
# 3,818
Out of 5,180 analysts
16
Total ratings
36.36%
Success rate
-8.28%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JNJ Johnson & Johnson | Maintains: Buy | $265 → $280 | $242.49 | +15.47% | 3 | Mar 17, 2026 | |
| LH Labcorp Holdings | Upgrades: Buy | n/a | $263.61 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $116.33 | +93.42% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $187.57 | +82.33% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $136.34 | -49.39% | 2 | Apr 24, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $261.79 | +106.27% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $61.27 | -15.13% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $166.16 | +56.48% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $349.00 | -8.31% | 1 | Sep 6, 2023 | |
| ATNM Actinium Pharmaceuticals | Initiates: Buy | $12 | $0.99 | +1,071.72% | 1 | Sep 6, 2023 |
Johnson & Johnson
Mar 17, 2026
Maintains: Buy
Price Target: $265 → $280
Current: $242.49
Upside: +15.47%
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $263.61
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $116.33
Upside: +93.42%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $187.57
Upside: +82.33%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $136.34
Upside: -49.39%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $261.79
Upside: +106.27%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $61.27
Upside: -15.13%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $166.16
Upside: +56.48%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $349.00
Upside: -8.31%
Actinium Pharmaceuticals
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $0.99
Upside: +1,071.72%